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Abstract
Quantitative real-time PCR (qPCR) is implemented in many molecular laboratories worldwide for the quantification of
viral nucleic acids. However, over the last two decades, there has been renewed interest in the concept of digital PCR
(dPCR) as this platform offers direct quantification without the need for standard curves, a simplified workflow and the
possibility to extend the current detection limit. These benefits are of great interest in terms of the quantification of low
viral levels in HIV reservoir research because changes in the dynamics of residual HIV reservoirs will be important to monitor
HIV cure efforts.
Here, we have implemented a systematic literature screening and text mining approach to map the use of droplet dPCR
(ddPCR) in the context of HIV quantification. In addition, several technical aspects of ddPCR were compared with qPCR:
accuracy, sensitivity, precision and reproducibility, to determine its diagnostic utility.
We have observed that ddPCR was used in different body compartments in multiple HIV-1 and HIV-2 assays, with the
majority of reported assays focusing on HIV-1 DNA-based applications (i.e. total HIV DNA). Furthermore, ddPCR showed
a higher accuracy, precision and reproducibility, but similar sensitivity when compared to qPCR due to reported false positive
droplets in the negative template controls with a need for standardised data analysis (i.e. threshold determination).
In the context of a low level of detection and HIV reservoir diagnostics, ddPCR can offer a valid alternative to qPCR-based
assays but before this platform can be clinically accredited, some remaining issues need to be resolved.
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Introduction
In the last two decades, quantitative real-time PCR (qPCR) has
become a standard tool in many molecular laboratories for the
quantification of viral nucleic acids and rigorously implemented
in accredited clinical testing [1]. Despite its success, qPCR remains
an indirect quantification method that relies on pre-validated
standard curves, and is susceptible to small changes in reaction
efficiency, which can substantially bias quantification due to the
logarithmic nature of a PCR reaction. In this context, digital PCR
(dPCR) provides an alternative type of technology that benefits
from direct quantification without the need for a standard curve,
and is associated with a better tolerance to small changes in PCR
efficiency [2,3].
The concept of dPCR-based quantification, initially called single
molecule PCR, was described before the invention of qPCR [4].
When using dPCR, a sample is divided into multiple partitions,
each representing an isolated end-point PCR reaction. In a
sufficiently diluted sample (at a limiting dilution), the distribution
of the template molecules within these partitions follows a Poisson
distribution. Consequently, this distribution can be used to deduce
the concentration of target nucleic acids in a sample from the
frequency of positive to negative partitions in the dPCR [5–7].
Notwithstanding the straightforward principle of dPCR, the high
costs and labour-intensive procedures to generate high numbers
of PCR partitions had hampered a wider use of dPCR until recently
[8]. Thanks to technological developments in microfluidics, a series
of digital PCR platforms has been developed that can generate
high numbers of PCR partitions per sample at a reasonable price
[9]. However, as with all new technologies, extensive optimisation
and validation are required to assess whether the newer technology
offers an improved platform for nucleic acid quantification and
is able to provide additional benefits.
The advantages of such technology are especially promising in
the setting of HIV reservoir and cure research because the
quantification of HIV reservoirs by PCR becomes challenging when
addressing small reservoir sizes and subtle changes in reservoir
dynamics [10]. Therefore, this review explores and compares dPCR
with qPCR applications in the field of HIV research in particular.
It also focuses on droplet digital PCR (ddPCR), as this is currently
the most frequently used dPCR platform (Figure 1).
Materials and methods
Systematic literature screen
We performed a systematic literature search of ddPCR in the context
of HIV quantification using the PubMed (www.ncbi.nlm.nih.gov/
pubmed) and ISI Web of Science databases. The following search
terms were used to construct the initial dataset of articles: ‘HIV’,
‘polymerase chain reaction’ and ‘PCR’. Next, only research articles
and English-language manuscripts were considered for the period
between November 2011 (first report on ddPCR) and March 2016.
In addition, the use of ddPCR was also searched for in clinical trials
related to HIV intervention studies with published articles (on
clinicaltrials.gov). Therefore, the following search term was used:
‘HIV reservoir’, with additional criteria: interventional studies received
from November 2011 until March 2016. Subsequently, all articles
were pooled together, duplicates were removed and text mining
was performed within the available full text articles using the
following search terms: ‘droplet digital PCR’ and ‘ddPCR’ (Appendix
1). The remaining set of articles was manually evaluated with the
following exclusion criteria: (1) ddPCRwas used for the quantification
of other assays than HIV; (2) only HIV qPCR was performed; (3)
review articles; (4) descriptive data analysis method; and (5) HIV
quantification was not performed on patient samples (Appendix 2).
Evaluation criteria for the comparison of ddPCR and qPCR
The ddPCR and qPCR platforms were compared in terms of their
different technical aspects, when data was available (Table 1).
*Corresponding author: Linos Vandekerckhove, HIV Translational Research
Unit, Department of Internal Medicine, De Pintelaan 185, Medical
Research Building 2, Ghent University, 9000 Ghent, Belgium
Email: linos.vandekerckhove@ugent.be
Journal of Virus Eradication 2016; 2: e1–e8 REVIEW
© 2016 The Authors. Journal of Virus Eradication published by Mediscript Ltd
This is an open access article published under the terms of a Creative Commons License. e1
Results
HIV quantification assays: systematic literature search
The systematic literature search on the use of droplet digital PCR
in the context of HIV quantification using patient samples resulted
19 articles that were included in this review (Figure 2).
HIVquantificationassays canbedivided intoPCR-andnon-PCR-based
approaches and are focused on the differentHIV forms/intermediates
(Table 2). Across all reports, we observed that ddPCR was used for
the quantification ofmultiple HIV-1 andHIV-2 forms/intermediates:
total HIV DNA, 2-LTR circles, HIV unspliced-RNA and HIV multiple-
splicedRNA(Figure3).Themajorityof assays includedHIVDNA-based
applications (total HIV DNA and 2-LTR circles) and ddPCR was not
only used for the quantification of integrated HIV DNA.
In the first part of this review, we have focused on reports that have
comparedddPCRandqPCRplatforms for different typesofHIVassays.
In the second part, we have described further
the applications of ddPCR in HIV research
according to the type of HIV assay.
Comparison of ddPCR- and qPCR-based
assays for HIV quantification
Since 2012, five reports have assessed and
used ddPCR as a novel quantitative tool in
HIV diagnostics and compared it to already-
validated qPCR platforms. In this review, we
have evaluated both platforms across these
reports regarding their technical aspects
(Table 3).
Assays for HIV DNA quantification
Henrich et al. performed the first comparison
between ddPCR and qPCR for the
quantification of total HIV DNA and 2-LTR
circles [14]. This was conducted using serial
dilutions of DNA standards on samples from HIV-infected patients
(n=7) who were on or off antiretroviral therapy (ART). The results
by qPCR and ddPCR quantification correlated well across all
conditions and showed a similar type of detection sensitivity.
However, differences in the absolute number of HIV DNA and
2-LTR circles were observed, with consistently higher numbers
measured by qPCR. The authors suggested some potential
explanations for this observation, including the effect of indirect
quantification by standard curve for qPCR (overestimation), or
decreased PCR efficiencies for ddPCR caused by incomplete DNA
restriction or overloading of the droplets with target DNA copies
(underestimation) [14]. Indeed, the latter was observed when
loading more than 75,000 DNA copies per droplet, showing the
need for samples to be diluted beyond this point. Finally, the
authors have commented on the need for automated and
reproducible threshold determination methods in order to increase
the reproducibility of ddPCR quantification.
(a) (b)
(c) (d)
Figure 1. Reported use of different digital PCR platforms over time in published articles from November 2011 until March 2016. The absolute numbers (a, c) and ratios in percentage
(b, d) are depicted for ddPCR vs non-ddPCR usage in a general dPCR context (a, b) and in an HIV-specific context (c, d)
Table 1. Overview of technical aspects used for comparison of ddPCR and qPCR
Technical aspect Definition
Accuracy bias The closeness of a single measurement to the true value [11,12]
Difference between the mean of measurements and the true value
[11,12]
Precision Closeness of agreement among replicate measurements on the same
sample [11,12]
Reproducibility Variation for the same measurement process among different
instruments, operators and over a longer period of time [11]
Sensitivity
Limit of detection
The smallest concentration of a analyte that can be reliably measured
by an analytical procedure [13]
Lowest analyte concentration likely to be reliably distinguished from
the limit of blank[13]
Limit of blank Highest ‘apparent’ analyte concentration found in a blank sample
[13]
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Figure 2. Overview of systematic pipeline used for this review
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A second comparison between ddPCR and qPCR for the
quantification of total HIV DNA and 2-LTR circles was made by
Strain et al., which involved an analysis of over 300 clinical samples
[16]. Here, ddPCR has shown an improved precision for total HIV
DNA quantification and better accuracy for the quantification of
2-LTR circles. Furthermore, the authors reported that ddPCR offers
an extra benefit for the quantification of micro-organisms with
high sequence variability, such as HIV, because of an increased
robustness to the mismatch of primers/probes with the target
sequence. Indeed, in their experimental setup, mismatches were
better tolerated by ddPCR than by qPCR, resulting in more accurate
quantification results. Lastly, Strain et al. observed the existence
of low numbers of false positive droplets in the negative template
control (NTC) and presented a new data-driven threshold
determination method to address the suboptimal threshold
calculations made by ddPCR manufacturers’ software (Quantasoft,
Bio-Rad).
A third and final comparison for a total HIV DNA assay was
conducted by Bosman et al. [28] and included two ddPCR
platforms (QX100, Bio-Rad and Raindrop, Raindance) and a
semi-nested qPCR on serial HIV DNA dilutions and samples from
ART-suppressed patients [28]. Semi-nested qPCRs are specifically
designed to reach higher sensitivity and accuracy as compared to
the standard qPCR. The QX100 ddPCR showed equal sensitivity
with the semi-nested qPCR but higher precision and efficiency,
corroborating the findings by Strain et al. [16]. However, low
numbers of false positive droplets in the NTCs were observed in
the ddPCR. These droplets displayed high fluorescence, making
them indistinguishable from the positive droplets in positive control
samples. The semi-nested qPCR did not result in false positive
samples. Hence, it was concluded that ddPCR outperforms qPCR
for accurate quantification of low levels of HIV DNA, but that a
semi-nested qPCR platform may be preferred if the focus is on
discriminating between the presence or absence of HIV DNA.
Assays for HIV RNA quantification
Two reports have discussed the comparison of qPCR and ddPCR
for HIV RNA assays, one for HIV-1 and one for HIV-2 [19,21].
Kiselinova et al. compared a semi-nested qPCR and ddPCR for
the quantification of cell-associated HIV-1 RNA (unspliced and
multiple spliced) [19]. This study highlighted that, in contrast to
DNA quantification, RNA quantification by dPCR still requires a
calibrator to correct for reverse transcription efficiency when
transforming the template RNA to PCR-compatible cDNA.
Furthermore, in this report, semi-nested qPCR showed better
accuracy and sensitivity on a synthetic RNA standard, especially
in the lower range of quantification. In contrast, ddPCR detected
multiple spliced HIV-1 RNA in a larger portion of patients, resulting
in higher sensitivity for that assay. However, a low number of false
positive droplets in the NTC were observed in the ddPCR readouts
(as described elsewhere [16,28]).
Interestingly, Kiselinova et al. [19] have also
reported false positive droplets in NTCs in
assays where either the forward or reverse
primer was lacking, but with the other primer
and probe in the reaction. This indicates that
false positive droplets do not always arise
from low levels of contamination, but may be
artefacts from the specific type of assay and
platform.
Concerning HIV-2 quantification, Ruelle et al.
[21] presented an optimised ddPCR assay for
plasma-free HIV-2 RNA (plasma viral load)
measurement and found that ddPCR
represented a more reproducible and sensitive
assay as compared with qPCR. However, these authors have
confirmed that false positive droplets in NTC remain an issue and
underlined the need for an accurate threshold determination
method before a transfer of ddPCR platforms into clinical testing.
ddPCR applications in HIV reservoir quantification studies
Droplet digital PCR has been increasingly used in different research
settings to address specific HIV-related topics. Across all reports,
ddPCR was most often used for the quantification of HIV DNA
(total HIV DNA and 2-LTR) in the context of the latent HIV
reservoir (Figure 3). In addition, different body compartments were
targeted for absolute ddPCR HIV quantification, such as blood,
rectal tissue and cerebrospinal fluid (CSF).
Total HIV DNA
de Oliveira et al. (2015) measured cell-associated HIV DNA levels
by ddPCR in the CSF and paired peripheral blood mononuclear
cell (PBMC) samples from 28 patients, 19 of whom were ART
suppressed with an undetectable plasma HIV RNA viral load (<50
HIV copies/mL) [30]. They found that HIV DNA levels in CSF were
comparable between ART-suppressed and non-suppressed patients,
but lower in PBMCs of suppressed patients. The authors concluded
that the CSF showed lower ART penetration and can harbour
ongoing viral replication with replenishment of the viral reservoir.
King et al. performed ddPCR for HIV DNA detection in infants
breast fed by HIV-infected mothers who were receiving post-natal
antiretroviral prophylaxis [29]. Here, ddPCR HIV DNA
quantification showed delayed detection of the virus with
prophylaxis, resulting in missed diagnosis in infants when HIV
testing was performed within 6 weeks after breastfeeding cessation.
In addition, a study performed by Yukl et al. [18] with blood and
tissue samples from the so-called Berlin patient who was reported
cured from HIV after receiving a bone marrow transplant from a
homozygous CCR5Δ32 donor [32]. Here, ddPCR was used to
characterise total HIV DNA in PBMCs in order to assess the impact
of potential curative interventions by bone marrow transplantation
[18]. No HIV DNA was detected in PBMCs but low levels of HIV
DNA were detected by qPCR in rectum samples. The authors state
that these low levels might represent a false positive result as no
HIV sequences could be retrieved from rectum samples and HIV
levels were near the limit of detection of the qPCR assay.
2-LTR circles
Hatano et al. monitored 2-LTR circles by means of ddPCR in a
randomised control study in HIV-suppressed patients receiving
either raltegravir intensification (n=15) or a placebo (n=16) [23].
They found an increase of 2-LTR circles over time in the group
receiving raltegravir. The authors state that this might indicate a
Table 2. Overview of reference methods for HIV reservoir quantification
HIV quantification method What is measured
PCR-based methods
Total HIV DNA Total pool of HIV DNA in the cell
Integrated HIV DNA Integrated fraction of HIV DNA in the genome
Episomal DNA Non-integrated circular DNA forms
Unspliced RNA Unprocessed RNA transcripts of HIV (full length HIV)
Multiple spliced RNA Processed RNA HIV transcripts
Non PCR-based methods
Viral outgrowth The replication competent fraction of HIV viruses
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low level of ongoing replication that can be blocked by raltegravir
intensification in ART-suppressed patients.
Another study that has looked at ART-suppressed patients (n=50)
was conducted by Ruggiero et al. [24]. Here, ddPCR was used
in the determination of 2-LTR circles in addition to a range of other
PCR-based HIV quantification assays and flow cytometry for
immunological markers (CD4 plus one of CD26/CD38/CD69, CD8
plus either one of CD38/HLA-DR/DP/DQ). No correlation was
found between 2-LTR circles with the HIV reservoir or the
immunological markers studied.
Total HIV DNA and 2-LTR circles
Pallikuth et al. looked into HIV permissiveness and persistence
in a subset of peripheral blood central memory T cells, namely
peripheral T follicular helper cells (Tfh) [25]. Total HIV DNA and
2-LTR circles were measured in chronically infected patients before
and after 48 weeks of raltegravir-based ART. Total HIV levels were
found to remain stable but those of 2-LTR circles decreased over
48 weeks of treatment in Tfh cells.
Eriksson et al. used ddPCR to monitor total HIV DNA and 2-LTR
circles and compared them using a non-PCR-based method that
detects replication-competent HIV (i.e. the viral outgrowth assay)
[15]. They found a discrepancy between the two methods, in so
far as PCR-based methods recorded higher levels of HIV than those
of replication-competent virus detected by the viral outgrowth
assays (VOA). The authors state that this might be due to the
substantial amount of replication-deficient HIV sequences found
in HIV-infected patients that are picked up by PCR-based assays
but not by the VOA [15]. In addition, more recent results indicate
that the VOA underestimates the amount of replication-competent
HIV DNA [33].
Total HIV DNA and cell-associated HIV RNA
Three studies have assessed ddPCR for total HIV DNA and
cell-associated HIV RNA quantification in various patient cohorts.
A first study by Kiselinova et al. used ddPCR in HIV RNA and DNA
measurements for the comparison of different ART regimens: a
standard ART backbone (two nucleoside reverse transcriptase
inhibitors) combined with nevirapine or a protease inhibitor [22,23].
No difference in HIV RNA and DNA was found between the two
treatment regimens. A second study by Malatinkova et al.
determined HIV DNA and RNA levels with ddPCR in two body
compartments (blood and rectal tissue) in different patient cohorts:
early treated seroconverters, chronically treated patients, ART-naïve
seroconverters and long-term non-progressors (LTNP) [24]. This
study confirmed that early treatment is associated with a small
viral reservoir and low levels of RNA transcription as compared
to later treatment initiation. However, total HIV DNA levels were
still higher than those of LTNPs [24]. In a third study, Kiselinova
et al. have looked further into the discrepancy between the
quantification results of the VOA and HIV DNA- and RNA PCR-
based methods in samples of patients on ART [31]. Here, total
HIV DNA levels were found to be higher than the replication-
competent levels measured by the VOA, corroborating earlier
findings by Eriksson et al. [15]. Additionally, the pool of total HIV
DNA correlated well with the replication-competent reservoir
measured by the VOA. Hence, the authors concluded that the
amount of latent replication-competent HIV in patients receiving
treatment can be predicted by measuring total HIV DNA levels
using PCR-based methods [31]. Therefore, these methods can still
be a useful tool in HIV eradication studies.
A last example of the use of ddPCR for the quantification of
cell-associated HIV-1 RNA and DNA is in HIV cure trials aimed
(a) (b)
ddPCR used in HIV assays
Authors Ref Total HIV DNA 2-LTR usRNA msRNA RNA viral load
Henrich et al. [14] x x
Erikssen et al. [15] x x
Strain et al. [16] x x
Hatano et al. x]71[
Yukl et al. [18] x
Kiselinova et al. xx]91[
Rasmussen et al. [20] x x
x]12[elleuR
Kiselinova et al. [22,23] x x x
Malatinkova et al. [24] x x x
Pallikuth et al. xxx]52[
Sogaard et al. [26] x x
Ruggiero et al. x]72[
Bosman et al. [28] x
King et al. [29] x
De Oliveira [30] x
Kiselinova [31] x x x x
syassAelcitrA
12
6
9
13
Total HIV DNA
2-LTR
usRNA
msRNA
RNA viral load
Figure 3. Overview of ddPCR HIV assays across all reports. Table view (a) and pie chart (b) of reported use of the assay across all reports based on Table 3
Table 3. Comparison of ddPCR and qPCR in HIV quantification assays. Colour scale indicates whether qPCR (blue) or ddPCR (green) was superior on a
certain technical aspect or when both platforms showed equal performance (orange). –: no data available
Report Virus Assay Accuracy and bias Precision Sensitivity Limit of detection Reproducibility
1 Henrich et al. [14] HIV-1 Total HIV DNA – – equal – –
2-LTR circles – – equal – –
2 Strain et al. [16] HIV-1 Total HIV DNA ddpcr ddpcr – ddpcr ddpcr
2-LTR circles ddpcr ddpcr – ddpcr ddpcr
3 Kiselinova et al. [19] HIV-1 usRNA qpcr – qpcr equal –
msRNA qpcr – qpcr ddpcr –
4 Bosman et al. [28] HIV-1 Total HIV DNA – ddpcr equal – –
5 Ruelle et al. [21] HIV-2 RNA (viral load) – – ddpcr ddpcr ddpcr
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at eliminating the HIV latent reservoir. In this context, several
groups have reported the effect of various latency-reversing agents
(e.g. panobinostat, romidepsin) on stimulating the latent reservoir
[20,26].
Discussion
There has been renewed interest in the concept of digital PCR
since the introduction of new commercial (droplet) digital PCR
platforms [6,9]. The dPCR platforms have promised to be less
labour-intensive with lower turnaround times, which should be
attractive to many HIV research groups. Hence, comparison with
established qPCR platforms for nucleic acid quantification is
required.
The findings of this review confirm reports on ddPCR and qPCR
comparisons within the field of cancer diagnostics (prostate cancer)
and quantification of other viruses (e.g. cytomegalovirus),
suggesting that ddPCR offers greater precision, improved
reproducibility but with similar sensitivity to qPCR [1–3].
Furthermore, ddPCR benefits from direct quantification without
the need for standard curves and offers a platform that displays
higher robustness to primer and probe mismatches with the target
sequence, making this a desired platform for HIV quantification
as sequence heterogeneity is often observed. However, it must
be noted that the difference between ddPCR and the more
sensitive semi-nested qPCR is less clear [19,28]. None the less,
the transition from qPCR to ddPCR could simplify and improve
routine clinical/virological testing. However, before ddPCR can
be fully accepted as an improved alternative to qPCR, two
remaining issues have been reported that are discussed below.
The first involves ddPCR sensitivity and the presence of false
positive droplets. Multiple reports have stated the existence of
highly fluorescent droplets in negative template controls containing
template-free genomic DNA, referred to as ‘false positive droplets’
[16,19,28]. This phenomenon seems inherent to ddPCR platforms
(i.e. QX100 and QX200 Bio-Rad) and lowers the sensitivity of
ddPCR quantification. This issue is especially problematic in the
context of a low level of viral detection, as is the case for HIV
quantification in patients receiving optimal ART with suppressed
plasma viral load [14,16]. Therefore, extra quality-assurance steps
are mandatory and crucial in order to identify and exclude false
positive droplets and to achieve a higher sensitivity. In this context,
new dPCR technologies that implement quality control for
identifying false positive droplets could offer a (hardware) solution
for this problem.
The second issue involves the standardised threshold
determination. Ruelle et al. commented on the need for a
standardised automated threshold setting, as the software methods
provided by the current ddPCR platform manufacturers are not
disclosed and often result in suboptimal quantification [21]. In
this context, three alternative threshold determination methods
are described to further improve reproducible data analysis:
clustering methods [16,34], global manual threshold [35] and
ddpcRquant [36].
Strain et al. were first to suggest a clustering-based method to
identify positive and negative droplet populations by calculating
two thresholds to delineate these two populations. Droplets that
fall outside these intervals, referred to as ‘rain’, are discarded and
excluded from further concentration calculations [16]. Jones et
al. have discussed a similar approach, ‘definetherain’, which is
based on k-nearest neighbour clustering to discriminate negative
from positive droplet populations [34].
However, our group has shown that droplets considered as rain
can contain genuine HIV sequences with mismatches in the primer
or probe binding region [36]. Hence, the elimination of droplets
can bias quantitative outcomes, especially in the context of some
viral or bacterial genomes where a high frequency in sequence
variation is observed [16]. The global manual threshold method
offers a single threshold determination that is calculated as six
times the standard deviation of the negative droplet population
and, in contrast to definetherain, it includes droplets with
intermediate fluorescence (rain) [35]. Both the definetherain and
global manual threshold data analysis methods assume a normal
distribution of the droplet fluorescence. However, this assumption
seldom holds true and can affect the correct allocation of
thresholds or clusters [36]. Therefore, we have recently described
an alternative statistical framework, ddpcRquant, to allocate
thresholds based on an extreme value theory, which is independent
of the underlying distribution of the total negative droplets. The
ddpcRquant algorithm also accounts for shifts in baseline
fluorescence between samples that can alter the correct droplet
allocation (code and web tool interface available at
www.ddpcrquant.ugent.be) [36].
Conclusion and future perspectives
There is growing interest in improving the sensitivity/detection
limit of qPCR. In this context, dPCR platforms could represent an
improved solution. However, the currently available platforms still
struggle to fulfil these promises and the needs of the different
end-users across multiple research domains. For the application
in viral detection, ddPCR holds an inherent advantage over qPCR
because of higher robustness to mismatches between the template
and primers/probe. On the other hand, the reports of false positive
droplets in NTCs remain a hurdle when attempting to reach higher
sensitivity and, although new threshold determination methods
offer a more reliable means of quantification, they are not
applicable to all ddPCR experimental setups. These issues will need
to be further addressed with costs to be further reduced in order
for ddPCR to make its way into the clinically accredited setting.
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Appendix 1: Text mining approach
All articles resulting from the initial screening were searched for full-text availability through Endnote (X7) and this resulted in 2206
full-text pdfs. Next, Linux Bash commands were used for text mining:
sfind . -name “*.pdf” -size -12M -print0 | xargs -0 pdfgrep -I -m 1 ‘droplet digital PCR | ddPCR’ 1> ddpcr_articles.txt 2> error.txt
Appendix 2: Table of articles reviewed
Article Included Exclusion criteria
1. Not HIV ddPCR
quantification assay
2. Only
HIV qPCR
3. Review 4. Data analysis
method
5. Not in context
of patient samples
1 Henrich 2012 Yes
2 De Spiegelaere 2013 No
3 Eriksson 2013 Yes
4 Hatano 2013 Yes
5 Jangam 2013 No x
6 Kibirige 2013 No x
7 Massanella 2013 No x
8 Selck 2013 No x
9 Strain 2013 Yes
10 Yukl 2013 Yes
11 Bharuthram 2014 No x
12 Beliakova-Bethe 2014 No x
13 Kiselinova 2014a Yes
14 Kiselinova 2014b Yes
15 Jones 2014 No x
16 Malatinkova 2014 Yes
17 Mitchell 2014 No x
18 Rasmussen 2014 Yes
19 Ruelle 2014 Yes
20 Bosman 2015 Yes
21 de Oliveira 2015 Yes
22 Janocko 2015 No x
23 King 2015 Yes
24 Kiselinova 2015 Yes
25 Li 2015 Yes x
26 Malatinkova 2015a Yes
27 Malatinkova 2015b Yes
28 Mock 2015 No x
29 Pallikkuth 2015 Yes
30 Perez-Santiago 2015 No x
31 Procopio 2015 No x
32 Rosadas 2015 No x
33 Ruggiero 2015 Yes
34 Sogaard 2015 Yes
35 Trypsteen 2015 No x
36 Hong 2016 No x
37 Massanella 2016 No x
38 Sedlak 2016 No x
39 Valentini 2016 No x
40 Var 2016 No x
41 Whale 2016 No x
42 Kiselinova 2016 Yes
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